Ninke Leffers

3.2k total citations · 1 hit paper
26 papers, 2.5k citations indexed

About

Ninke Leffers is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ninke Leffers has authored 26 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Immunology, 14 papers in Oncology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ninke Leffers's work include Immunotherapy and Immune Responses (20 papers), Immune Cell Function and Interaction (13 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Ninke Leffers is often cited by papers focused on Immunotherapy and Immune Responses (20 papers), Immune Cell Function and Interaction (13 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Ninke Leffers collaborates with scholars based in Netherlands, United States and France. Ninke Leffers's co-authors include Hans W. Nijman, Toos Daemen, Marloes J.M. Gooden, Geertruida H. de Bock, Ate G.J. van der Zee, Klaske A. ten Hoor, Harry Hollema, Renske A. de Jong, Baukje‐Nynke Hoogeboom and Sjoerd H. van der Burg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Clinical Cancer Research and Cochrane Database of Systematic Reviews.

In The Last Decade

Ninke Leffers

26 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis

2011 994 citations Marloes J.M. Gooden, Geertruida H. de Bock et al. British Journal of Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ninke Leffers Netherlands	21	1.7k	1.6k	363	272	236	26	2.5k
Marloes J.M. Gooden Netherlands	12	1.3k 0.8×	1.1k 0.7×	262 0.7×	115 0.4×	216 0.9×	12	1.8k
Marcella Fassò United States	25	2.1k 1.2×	1.3k 0.8×	357 1.0×	94 0.3×	725 3.1×	42	2.9k
Keren Coplan United States	21	1.2k 0.7×	1.3k 0.9×	1.1k 3.1×	87 0.3×	435 1.8×	25	2.6k
Bruria Shalmon Israel	17	1.1k 0.6×	834 0.5×	339 0.9×	41 0.2×	73 0.3×	31	1.6k
Andrew S. Brohl United States	22	1.2k 0.7×	346 0.2×	426 1.2×	45 0.2×	528 2.2×	100	2.0k
Norihiro Teramoto Japan	25	940 0.5×	289 0.2×	305 0.8×	160 0.6×	582 2.5×	125	2.2k
Theresa L. Pasha United States	23	686 0.4×	194 0.1×	408 1.1×	166 0.6×	466 2.0×	39	1.7k
Harry Klip Netherlands	21	407 0.2×	324 0.2×	525 1.4×	176 0.6×	82 0.3×	28	1.2k
Makiko Itami Japan	20	636 0.4×	194 0.1×	357 1.0×	138 0.5×	544 2.3×	89	1.7k
Chiara Romani Italy	22	407 0.2×	243 0.2×	498 1.4×	493 1.8×	172 0.7×	58	1.6k

Countries citing papers authored by Ninke Leffers

Since Specialization

Citations

This map shows the geographic impact of Ninke Leffers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ninke Leffers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ninke Leffers more than expected).

Fields of papers citing papers by Ninke Leffers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ninke Leffers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ninke Leffers. The network helps show where Ninke Leffers may publish in the future.

Co-authorship network of co-authors of Ninke Leffers

This figure shows the co-authorship network connecting the top 25 collaborators of Ninke Leffers. A scholar is included among the top collaborators of Ninke Leffers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ninke Leffers. Ninke Leffers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Paijens, Sterre T., Ninke Leffers, Toos Daemen, et al.. (2018). Antigen-specific active immunotherapy for ovarian cancer. Cochrane Database of Systematic Reviews. 2018(9). 15 indexed citations

Gooden, Marloes J.M., Valerie R. Wiersma, Annemarie Boerma, et al.. (2014). Elevated serum CXCL16 is an independent predictor of poor survival in ovarian cancer and may reflect pro-metastatic ADAM protease activity. British Journal of Cancer. 110(6). 1535–1544. 30 indexed citations

Leffers, Ninke, Toos Daemen, Wijnand Helfrich, et al.. (2014). Antigen-specific active immunotherapy for ovarian cancer. Cochrane Database of Systematic Reviews. 9(9). CD007287–CD007287. 24 indexed citations

Vermeij, Renee, Ninke Leffers, Cornelis J.M. Melief, Toos Daemen, & Hans W. Nijman. (2012). Antigen-specific Immunotherapy in Ovarian Cancer and p53 as Tumor Antigen. Current Pharmaceutical Design. 18(25). 3804–3811. 12 indexed citations

Vermeij, Renee, Ninke Leffers, Baukje‐Nynke Hoogeboom, et al.. (2011). Potentiation of a p53‐SLP vaccine by cyclophosphamide in ovarian cancer: A single‐arm phase II study. International Journal of Cancer. 131(5). E670–80. 72 indexed citations

Leffers, Ninke, Renee Vermeij, Baukje‐Nynke Hoogeboom, et al.. (2011). Long‐term clinical and immunological effects of p53‐SLP® vaccine in patients with ovarian cancer. International Journal of Cancer. 130(1). 105–112. 43 indexed citations

Gooden, Marloes J.M., Geertruida H. de Bock, Ninke Leffers, Toos Daemen, & Hans W. Nijman. (2011). The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis. British Journal of Cancer. 105(1). 93–103. 994 indexed citations breakdown →

Vermeij, Renee, Ninke Leffers, Sjoerd H. van der Burg, et al.. (2011). Immunological and Clinical Effects of Vaccines Targeting p53‐Overexpressing Malignancies. BioMed Research International. 2011(1). 702146–702146. 37 indexed citations

Vermeij, Renee, Geertruida H. de Bock, Ninke Leffers, et al.. (2011). Tumor-infiltrating Cytotoxic T Lymphocytes as Independent Prognostic Factor in Epithelial Ovarian Cancer With Wilms Tumor Protein 1 Overexpression. Journal of Immunotherapy. 34(6). 516–523. 27 indexed citations

10.

Leffers, Ninke, et al.. (2011). Vaccine-based clinical trials in ovarian cancer. Expert Review of Vaccines. 10(6). 775–784. 9 indexed citations

11.

Vermeij, Renee, Ninke Leffers, Baukje‐Nynke Hoogeboom, et al.. (2011). Potentiation of a P53-SLP vaccine by cyclophosphamide in ovarian cancer, A single ARM phase II study. Data Archiving and Networked Services (DANS). 21(12). 28 indexed citations

12.

Leffers, Ninke, Rudolf S.N. Fehrmann, Marloes J.M. Gooden, et al.. (2010). Identification of genes and pathways associated with cytotoxic T lymphocyte infiltration of serous ovarian cancer. British Journal of Cancer. 103(5). 685–692. 38 indexed citations

13.

Vermeij, Renee, Toos Daemen, Geertruida H. de Bock, et al.. (2010). Potential Target Antigens for a Universal Vaccine in Epithelial Ovarian Cancer. Journal of Immunology Research. 2010(1). 23 indexed citations

14.

Bijen, Claudia B.M., Renske A. de Jong, Ninke Leffers, et al.. (2009). The prognostic role of classical and nonclassical MHC class I expression in endometrial cancer. International Journal of Cancer. 126(6). 1417–1427. 59 indexed citations

15.

Leffers, Ninke, Marloes J.M. Gooden, W. Martin Kast, et al.. (2009). Down-regulation of proteasomal subunit MB1 is an independent predictor of improved survival in ovarian cancer. Gynecologic Oncology. 113(2). 256–263. 22 indexed citations

16.

Jong, Renske A. de, Ninke Leffers, H. Marike Boezen, et al.. (2009). Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer. Gynecologic Oncology. 114(1). 105–110. 179 indexed citations

17.

Leffers, Ninke, Annechien J.A. Lambeck, Marloes J.M. Gooden, et al.. (2009). Immunization with a P53 synthetic long peptide vaccine induces P53‐specific immune responses in ovarian cancer patients, a phase II trial. International Journal of Cancer. 125(9). 2104–2113. 109 indexed citations

18.

Leffers, Ninke, Annechien J.A. Lambeck, Pauline de Graeff, et al.. (2008). Survival of ovarian cancer patients overexpressing the tumour antigen p53 is diminished in case of MHC class I down-regulation. Gynecologic Oncology. 110(3). 365–373. 31 indexed citations

19.

Leffers, Ninke, Marloes J.M. Gooden, Renske A. de Jong, et al.. (2008). Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer. Cancer Immunology Immunotherapy. 58(3). 449–459. 335 indexed citations

20.

Lambeck, Annechien J.A., Ninke Leffers, Baukje‐Nynke Hoogeboom, et al.. (2007). P53‐specific T cell responses in patients with malignant and benign ovarian tumors: Implications for p53 based immunotherapy. International Journal of Cancer. 121(3). 606–614. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact